Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 24; no. 13; pp. 2027 - 2028
Main Authors Fietzek, Urban M., Schroeteler, Frauke E., Ceballos-Baumann, Andres O.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.10.2009
Subjects
Aged
Botulinum Toxins - therapeutic use
Botulinum Toxins, Type A
Disability Evaluation
Female
Humans
Male
Neuromuscular Agents - therapeutic use
Parkinsonian Disorders - complications
Spinal Curvatures - drug therapy
Spinal Curvatures - etiology
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:Merz Pharmaceuticals GmbH
ArticleID:MDS22676
Potential conflict of interest: Merz Pharmaceutical GmbH, Frankfurt, Germany did not design the work, nor collect, analyze or interpret data, nor write any part of this report.
Frankfurt, Germany
istex:4902A8B3BB18DCB46BD69AF74DC09B13FFC9DA96
ark:/67375/WNG-ZQQCZCD7-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.22676